Calidi Biotherapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $16.5M | $231.8M | $1.1M |
| FY2022 | $43.4M | $2.6M | $590.0K |
| FY2023 | $18.3M | $10.0M | $2.2M |
| FY2024 | $12.2M | $14.2M | $9.6M |
| FY2025 | $5.1M | $8.9M | $5.8M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $16.5M | $231.8M | $1.1M |
| FY2022 | $43.4M | $2.6M | $590.0K |
| FY2023 | $18.3M | $10.0M | $2.2M |
| FY2024 | $12.2M | $14.2M | $9.6M |
| FY2025 | $5.1M | $8.9M | $5.8M |